ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Role of Tacrolimus Dose Adjustment at Discontinuation of Fluconazole in Liver Transplant

J. Yau, H. Morris

University of Virginia Health System, Charlottesville, VA

Meeting: 2020 American Transplant Congress

Abstract number: A-133

Keywords: Calcineurin, Drug interaction, Liver transplantation, Prophylaxis

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: Liver: Immunosuppression and Rejection

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Impact of Fluconazole Prophylaxis on Fungal Infections in Liver Transplant Recipients
  • Once Weekly Fluconazole is Effective for the Prevention of Oral Candidiasis in Kidney Transplant Recipients

*Purpose: The purpose of this study was to characterize the effects of fluconazole (fluc) discontinuation on tacrolimus (tac) levels and the role of prophylactic dose adjustments of tac.

*Methods: Thrush prophylaxis in liver transplant recipients during the early post-transplant period is common practice. Due to shortages of nystatin and clotrimazole in 2018, systemic thrush prophylaxis with fluc was initiated for 30 days post-transplant. This is a retrospective single center study from March 2019 to September 2019. Liver transplant recipients were included for chart review if they were simultaneously on tac and fluc prophylaxis after transplant, and recipients were excluded if tac was discontinued or switched to another agent, patients were prescribed another known CYP3A4/5 inhibitor, or multi-organ transplant.

*Results: Thirty patients were included in the final data analysis. The mean duration of fluc therapy was 28.7 days, 67% of patients received < 30 days of fluc (20/30); 8 patients received fluc for 31-32 days and 2 for more than 35 days. The majority of patients had a tac goal of 8-10; 33% (10/30) of patients had a documented reduced tac goal, mostly associated with elevated serum creatinine. Prior to discontinuation of fluc, 30% of patients (9/30) had supratherapeutic tac levels, 30% (9/30) had subtherapeutic levels, and 40% (12/30) were therapeutic. For the supratherapeutic group, tac total daily dose (TDD) was not adjusted prophylactically; ≥4 days after fluc was completed 2/9 remained supratherapeutic, 4/9 became therapeutic, and 3/9 became subtherapeutic. In the subtherapeutic group, 5/9 had their TDD prophylactically increased before fluc cessation, and 2/9, 4/9, and 3/9 became supratherapeutic, therapeutic, or remained subtherapeutic. Of the therapeutic patients, 11/12 (92%) did not have their tac dose increased prophylactically, and 9/12 (75%) became subtherapeutic > 4 days after fluc cessation. Mean time to a therapeutic level after fluc discontinuation was 15.3 days in this group. Also among the supratherapeutic patients, 8/9 had an increase in serum creatinine associated with the supratherapeutic level (6/9 had an increase in serum creatinine of > 0.4 from time of discharge). In the supratherapeutic group 6/9 experienced hyperkalemia versus 2/9 in the subtherapeutic group, though this difference was not statistically significant (p=0.058).

*Conclusions: These results highlight the importance of adjusting tac upon discontinuation of an interacting medication such as fluconazole, and the potential for pharmacist intervention in ambulatory transplant clinics. It also identifies the potential benefit of standardizing timing of dose adjustment by pharmacists or nurse coordinators.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yau J, Morris H. Role of Tacrolimus Dose Adjustment at Discontinuation of Fluconazole in Liver Transplant [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/role-of-tacrolimus-dose-adjustment-at-discontinuation-of-fluconazole-in-liver-transplant/. Accessed April 18, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.